The FDA has linked a fungal meningitis outbreak to potentially contaminated methylprednisolone acetate from NECC, though the exact source of the outbreak is still ongoing.
However, the FDA has observed fungal contamination from a sealed vial of the injectable steroid produced and distributed by NECC and is conducting additional testing to confirm the exact species of fungus.
As a precaution, governmental officials recommend discontinuing use of all NECC products while retaining and securing all remaining products purchased from NECC until the FDA provides instructions on disposal.
More Articles on Anesthesia:
Study: Lighter Anesthesia Does Not Improve Mortality Rates for Certain Patients
CBIZ Acquires ProMedical Anesthesia Billing Company
Lawmakers Concerned by Policy to Allow Patients to Report Medical Mistakes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
